MSB News and Press, Mesabi Trust From 09/11/25

Globus Maritime Limited (GLBS) is expected to report for quarter end 2025-06-30 Cerro Grande Mining Corp (CEGMF) is expected to report for quarter end 2025-06-30 Scinai Immunotherapeutics Ltd. (SCNI) is expected to report for quarter end 2025-06-30 HOOKIPA Pharma Inc. (HOOK) is expect...

2025-09-08 09:28:33 ET Mesabi Trust ( MSB ) owns mining rights at Peter Michell Mine, in northeastern Minnesota, within the Mesabi Iron Range. However, according to the Trust’s agreement rules, Mesabi is not allowed to do any business on its land, it can only rece...

Scinai Immunotherapeutics Ltd. (SCNI) is expected to report for quarter end 2025-06-30 World Copper (WCUFF) is expected to report for quarter end 2025-06-30 HOOKIPA Pharma Inc. (HOOK) is expected to report for Q2 2025 Phoenix Footwear Group, Inc. (PXFG) is expected to report for quart...

NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced it has entered into convertible note subscription agreements with SurgCenter principals and existing Mesoblast sharehold...

NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today provided financial results and an operational update for the period ended June 30, 2025. Mesoblast Chief Executive Dr. Silviu I...

NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the full year ended June 30, 2025. The webcast will b...

NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue from sales of Ryoncil ® (remestemcel-L-rknd) through the first quarter post product launch. Ry...

Announcement of Mesabi Trust Distribution The Trustees of Mesabi Trust (NYSE:MSB) declared a distribution of twelve cents ($0.12) per Unit of Beneficial Interest payable on August 20, 2025 to Mesabi Trust Unitholders of record at the close of business on July 30, 2025. This com...

NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced alignment with the United States Food and Drug Administration (FDA) on items required for filing a Biologics License Application ...

2025-06-17 03:15:19 ET Foreword Read the full article on Seeking Alpha For further details see: Buy 6 Ideal Safe Dividend Power Dogs For June